{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/452971253"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The second company, which would keep the Abbott name, will sell heart stents, infant formulas, generic drugs and other products expected to bring in $22 billion this year." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "newsmax.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/7565517"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/452971253" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/346600772"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/452971253"] } } }
